BioLife Solutions, Inc. Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted
BioLife Solutions, Inc. (BLFS) reported Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted of -$15.84 million for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-07.
Financial Statements › Income Statement › Other Income
us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted · last filed 2025-08-07
- BioLife Solutions, Inc. net income (loss) from continuing operations available to common shareholders, diluted for the quarter ending 2025-06-30 was -$15.84M.
- BioLife Solutions, Inc. net income (loss) from continuing operations available to common shareholders, diluted for the quarter ending 2025-03-31 was -$448.00K.
- BioLife Solutions, Inc. net income (loss) from continuing operations available to common shareholders, diluted for the quarter ending 2024-09-30 was -$1.70M.
- BioLife Solutions, Inc. net income (loss) from continuing operations available to common shareholders, diluted for the quarter ending 2024-06-30 was -$5.56M.
| Period end | Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted 3 month | Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted 3 month as first filed | Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted 6 month | Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted 6 month as first filed | Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted 9 month |
|---|---|---|---|---|---|
| 2025-06-30 | -$15.84M 10-Q · filed 2025-08-07 | -$16.29M 10-Q · filed 2025-08-07 | |||
| 2025-03-31 | -$448.00K 10-Q · filed 2025-05-08 | ||||
| 2024-09-30 | -$1.70M 10-Q · filed 2024-11-12 | -$7.26M derived: sum of 2 quarters · filed 2025-08-07 | -$13.06M 10-Q · filed 2024-11-12 | ||
| 2024-06-30 | -$5.56M 10-Q · filed 2025-08-07 | -$7.15M 10-Q · filed 2024-08-09 | -$8.76M 10-Q · filed 2025-08-07 | -$11.36M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | -$3.20M 10-Q · filed 2025-05-08 | ||||
| 2023-09-30 | -$15.80M 10-Q · filed 2024-11-12 | -$21.32M derived: sum of 2 quarters · filed 2024-11-12 | -$30.04M 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | -$5.52M 10-Q · filed 2024-08-09 | -$14.24M 10-Q · filed 2024-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |